Join to view full profile
5298 Socialville Foster RdMason, OH 45040
Phone+1 513-770-4212
Fax+1 513-770-4213
Dr. Uhlenhake is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Dermatopathology, 2013 - 2014
Wayne State University School of MedicineResidency, Dermatology, 2010 - 2013
Kettering Health Network/Kettering Medical CenterInternship, Transitional Year, 2009 - 2010
Northeast Ohio Medical UniversityClass of 2009
Certifications & Licensure
IL State Medical License 2021 - 2029
NH State Medical License 2018 - 2028
NY State Medical License 2026 - 2028
CA State Medical License 2017 - 2027
FL State Medical License 2017 - 2027
IN State Medical License 2019 - 2027
KY State Medical License 2020 - 2027
American Board of Dermatology Dermatology- American Board of Dermatology Dermatopathology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MatrixCare, MatrixCare, 2016
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, 2016
Publications & Presentations
PubMed
- 8 citationsPemphigoid gestationis and intravenous immunoglobulin therapy.Anes Yang, Elizabeth Uhlenhake, Dedee F. Murrell
International Journal of Women's Dermatology. 2018-05-03 - 14 citationsNuclear factor XIIIa staining (clone AC‐1A1 mouse monoclonal) is a highly sensitive marker of sebaceous differentiation in normal and neoplastic sebocytesLindsey N. Clark, Hillary Elwood, Elizabeth E. Uhlenhake, Bruce R. Smoller, Sara C. Shalin
Journal of Cutaneous Pathology. 2016-08-01 - 10 citationsNuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear ce...Elizabeth E. Uhlenhake, Lindsey N. Clark, Bruce R. Smoller, Sara C. Shalin, Jerad M. Gardner
Journal of Cutaneous Pathology. 2016-06-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
